Peru's new president is controversial. Here's why scientists have high hopes for him | Science science.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from science.org Daily Mail and Mail on Sunday newspapers.
Lima archbishop proposes replacing priests with laity as pastors catholicworldreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from catholicworldreport.com Daily Mail and Mail on Sunday newspapers.
2021-07-21 03:36:14 GMT2021-07-21 11:36:14(Beijing Time) Xinhua English LIMA, July 20 (Xinhua) The declaration of Pedro Castillo being the president-elect of Peru has generated high hopes among the people, who expect him to bring about change, political observer Jerjes Loayza said Tuesday. In an interview with Xinhua, the sociologist and professor at the National University of San Marcos said the expectation is that the progressive candidate of the Free Peru party, who takes office July 28, will lead a more social-democratic government. Asked about Castillo s campaign pledges, Loayza said his ability to deliver on those promises will depend on how political negotiations pan out in Congress, which is scheduled to be installed on July 27.
Rwanda emerges as world leader in the fight against Covid-19 – leading macroeconomic influencers 8 January 2021 (Last Updated January 8th, 2021 08:02) Economists believe that despite poor healthcare systems marked by lack of ventilators, intensive care unit beds, and funds, Rwanda has emerged as a clear winner in the fight against Covid-19. One of Zipline’s drones delivering medical supplies in Rwanda. Credit: Gavi/2018/KAREL PRINSLOO Share Article Economists believe that despite poor healthcare systems marked by lack of ventilators, intensive care unit beds, and funds, Rwanda has emerged as a clear winner in the fight against Covid-19, reporting low mortalities and virus spread through community participation, equity, trust and patient centrism.
Outrage over university COVID vaccine trial scandal Nature 03 April 2021 A clinical trial of COVID-19 vaccines in Peru has sparked outrage and triggered a series of high-profile resignations at universities and in government. Politicians, researchers and some of their family members who were not enrolled as trial participants nevertheless received vaccines, breaching standard protocols. Investigations are ongoing as the country struggles to inoculate its general population with limited doses, writes Luke Taylor for Nature. The scandal emerged on 10 February, when local media revealed that in October 2020, then-president Martín Vizcarra had received two doses of a vaccine developed by the Chinese state-owned pharmaceutical group Sinopharm. At the time, a phase III clinical trial was under way to test the vaccine at two universities in Peru; Vizcarra was not part of the trial. Days later, it emerged that a group of around 470 other people – including 100 high-profile individuals such as Peru’s minister of health and Vizcarra’s wife and brother – also got a jab while the trial was in progress. The shots came from a batch of about 2,000 doses that Peruvian officials reportedly negotiated with Sinopharm to protect the medical staff running the trial.
Timeline: Latin America's Road to Get Vaccinated as-coa.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from as-coa.org Daily Mail and Mail on Sunday newspapers.
A staff member tests samples of the COVID-19 inactivated vaccine at a vaccine production base of the Beijing Biological Products Institute Co., Ltd. in Beijing, capital of China, April 11, 2020. (Xinhua/Zhang Yuwei) According to Peru's National Institute of Health, which is overseeing the process, 11,000 volunteers have been vaccinated since the trials began in September. LIMA, Jan. 6 (Xinhua) Peru has signed an agreement with Chinese.